Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H14FN3O5S |
| Molecular Weight | 367.352 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(F)C=C1S(=O)(=O)NC2=CN=C3OCCNC(=O)C3=C2
InChI
InChIKey=KHCUGFQNACXROB-UHFFFAOYSA-N
InChI=1S/C15H14FN3O5S/c1-23-12-3-2-9(16)6-13(12)25(21,22)19-10-7-11-14(20)17-4-5-24-15(11)18-8-10/h2-3,6-8,19H,4-5H2,1H3,(H,17,20)
| Molecular Formula | C15H14FN3O5S |
| Molecular Weight | 367.352 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 21:11:20 GMT 2025
by
admin
on
Tue Apr 01 21:11:20 GMT 2025
|
| Record UNII |
4Y1C1S2WCI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
705419
Created by
admin on Tue Apr 01 21:11:20 GMT 2025 , Edited by admin on Tue Apr 01 21:11:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4Y1C1S2WCI
Created by
admin on Tue Apr 01 21:11:20 GMT 2025 , Edited by admin on Tue Apr 01 21:11:20 GMT 2025
|
PRIMARY | |||
|
124187747
Created by
admin on Tue Apr 01 21:11:20 GMT 2025 , Edited by admin on Tue Apr 01 21:11:20 GMT 2025
|
PRIMARY | |||
|
2062664-81-5
Created by
admin on Tue Apr 01 21:11:20 GMT 2025 , Edited by admin on Tue Apr 01 21:11:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
![Structure of 5-Fluoro-2-methoxy-N-(2,3,4,5-tetrahydro-5-oxopyrido[3,2-f]-1,4-oxazepin-7-yl)benzenesulfonamide](/img/623bdaa7-04f5-420f-82b1-2a7bcf787c38.svg "Structure of 5-Fluoro-2-methoxy-N-(2,3,4,5-tetrahydro-5-oxopyrido[3,2-f]-1,4-oxazepin-7-yl)benzenesulfonamide")